BRCA2 and prostate cancer: We observed that BRCA1 pathogenic variants affect prostate cancer aggressiveness such as BRCA2 pathogenic variants, and the first case of aggressive prostate cancer with a BRCA1 pathogenic variant had long-term survival through early detection and multidisciplinary treatment.